Bankier Alain D 4
4 · Intiva BioPharma Inc. · Filed Sep 5, 2018
Insider Transaction Report
Form 4
Bankier Alain D
Director
Transactions
- Other
Class C Warrants (right to buy)
2018-08-06−28,000→ 0 totalExercise: $0.50From: 2017-11-29Exp: 2018-08-08→ Common Stock (28,000 underlying) - Other
Class D Warrants (right to buy)
2018-08-06+28,000→ 28,000 totalExercise: $1.00From: 2018-08-06Exp: 2018-09-28→ Units (28,000 underlying)
Holdings
- 100,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2023-07-25→ Common Stock (100,000 underlying) - 840,000
Stock option - right to buy
Exercise: $0.54From: 2018-07-25Exp: 2023-07-25→ Common Stock (840,000 underlying) - 2,256,000
Common Stock
Footnotes (4)
- [F1]70,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
- [F2]25,000 options vested immediately, with the remainder vesting quarterly over the next 6 quarters beginning with the quarter ending September 30, 2018.
- [F3]Each unit consists of one share of common stock and one Class E Warrant.
- [F4]Class C Warrants were exchanged for an equal number of Class D Warrants.